CD274 and non-small cell lung carcinoma: Yang and colleagues also investigated blood PD-L1 dynamics, including exosomal PD-L1, PD-L1 mRNA, and sPD-L1 levels in plasma before and after 2 months of anti-PD-(L)1 in NSCLC patients (n = 40) [49].